Provision of MagNA Pure 96

Public Health England (PHE) has awarded a contract to Roche Diagnostics Limited to procure MagNA Pure 96.

This is part of a critical project to rapidly expand the SARS-CoV-2 sequencing capacity under the Genomics testing expansion slated for the 2nd half of 2021.